Vilin Bio Med

Vilin Bio Med

23.50
0.00
(0.00%)
Market Cap
32.78 Cr
EPS
0.16
PE Ratio
146.88
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
32.50
52 Week Low
16.25
PB Ratio
1.42
Debt to Equity
0.20
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,640.70
#1 3,93,658.89
34.30
#1 54,729.00
9.71
#1 10,980
-19.84
47.35
6,115.50
1,62,347.31
69.37
9,712.00
18.67
2,191
26.74
35.29
1,596.20
1,28,926.32
23.86
28,409.50
7.12
5,291
9.88
66.07
3,656.90
1,23,766.11
61.13
11,539.40
6.99
1,911
19.91
59.05
2,601.20
1,07,359.00
56.78
12,744.20
#1 20.90
2,007
-18.14
60.15
1,275.20
1,06,424.51
#1 18.75
33,741.20
16.73
5,725
1.26
57.30
989.45
99,561.82
21.29
23,511.00
18.55
4,615
2.60
56.17
1,969.90
89,964.44
24.22
22,909.50
13.74
3,306
#1 51.64
53.40
32,745.00
69,580.84
47.71
6,684.70
9.64
1,414
11.55
44.46
5,464.00
65,330.32
28.51
13,458.30
3.70
2,216
21.39
70.65
Forecast
Actual
Growth Rate
Revenue Growth
-4.97 %
Net Income Growth
-
Cash Flow Change
102.96 %
ROE
36.62 %
ROCE
13.73 %
EBITDA Margin (Avg.)
16.27 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
17
12
11
12
16
15
8
Expenses
16
11
10
10
15
14
7
EBITDA
1
1
1
3
1
1
2
Operating Profit %
5 %
7 %
7 %
21 %
5 %
5 %
8 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
1
1
1
1
0
Profit Before Tax
0
0
0
2
0
0
1
Tax
0
0
0
1
0
0
0
Net Profit
0
0
0
1
0
0
1
EPS in ₹
0.20
0.15
0.10
1.25
0.12
0.16
2.20

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
14
14
14
18
32
28
Fixed Assets
2
2
2
2
1
1
Current Assets
12
12
12
8
19
13
Capital Work in Progress
0
0
0
0
0
2
Investments
0
0
0
0
0
0
Other Assets
12
12
12
16
31
25
Total Liabilities
14
14
14
18
32
28
Current Liabilities
7
6
5
7
9
5
Non Current Liabilities
0
1
1
1
0
0
Total Equity
7
7
7
11
23
23
Reserve & Surplus
4
4
4
1
9
9
Share Capital
3
3
3
10
14
14

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
0
2
-6
Investing Activities
0
0
0
0
0
-1
Operating Activities
-2
-1
0
-2
-7
0
Financing Activities
2
1
-0
2
9
-5

Share Holding

% Holding
Jun 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Jun 2025
Promoter
90.45 %
64.52 %
64.52 %
64.09 %
63.89 %
63.89 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
9.45 %
32.80 %
33.84 %
34.47 %
34.18 %
33.49 %
Others
0.10 %
2.68 %
1.65 %
1.45 %
1.94 %
2.62 %
No of Share Holders
827
659
585
581
551
492

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
21 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Sept 2024 18.85 18.05
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2024 24.40 22.90
17 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
17 May 2025 25.35 26.55

Technical Indicators

RSI(14)
Neutral
34.45
ATR(14)
Volatile
0.92
STOCH(9,6)
Neutral
35.57
STOCH RSI(14)
Oversold
10.42
MACD(12,26)
Bearish
-0.27
ADX(14)
Weak Trend
17.31
UO(9)
Bullish
26.09
ROC(12)
Downtrend And Accelerating
-6.00
WillR(14)
Oversold
-100.00